Quarterly report pursuant to Section 13 or 15(d)

Note 14 - Segment Reporting - Segment Reporting Financial Information (Details)

v3.19.2
Note 14 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Revenues $ 11,170,000 $ 8,805,000 $ 21,849,000 $ 17,452,000
Operating income (loss) 487,600 (64,239) 1,431,274 (148,402)
Depreciation and amortization 404,000 405,000 770,143 792,392
Bargain purchase gain 30,455 19,298 30,455
Other income (expense), net (15,126) (11,103) (26,771) (21,910)
Loss before income tax expense 472,474 (44,887) 1,423,801 (139,857)
Operating Segments [Member]        
Operating income (loss) 3,195,000 1,924,000 6,424,000 4,205,000
Corporate, Non-Segment [Member]        
Operating income (loss) (2,707,000) (1,988,000) (4,993,000) (4,353,000)
Corporate Clinics [Member]        
Revenues 5,777,000 4,669,000 11,416,000 9,474,000
Operating income (loss) 564,000 (50,000) 1,404,000 416,000
Depreciation and amortization 353,000 245,000 666,000 548,000
Franchise Operations [Member]        
Revenues 5,393,000 4,136,000 10,433,000 7,978,000
Operating income (loss) 2,631,000 1,974,000 5,020,000 3,789,000
Depreciation and amortization
Corporate Segment [Member]        
Depreciation and amortization $ 51,000 $ 160,000 $ 104,000 $ 244,000